Sex hormones and sex chromosomes cause sex differences in the development of cardiovascular diseases

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 5, 2017, Pages 746-756

  Arnold, Arthur P ^a   Cassis, Lisa A ^b   Eghbali, Mansoureh ^a   Reue, Karen ^c   Sandberg, Kathryn ^c,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

androgen effects; atherosclerosis; coronary artery disease; estrogen effects; gonosomes; heart failure; obesity

Indexed keywords

ANDROGEN; ESTROGEN; SEX HORMONE;

ANEURYSM; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; GENE DOSAGE; GENOME IMPRINTING; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; KARYOTYPE 46,XX; MALE; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; OBESITY; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; SEX CHROMOSOME; SEX DIFFERENCE; X CHROMOSOME; Y CHROMOSOME; ANIMAL; CARDIOVASCULAR DISEASES; DISEASE MODEL; GENETIC PREDISPOSITION; GENETICS; HEALTH DISPARITY; METABOLISM; PHENOTYPE; PROTECTION; RISK FACTOR; TRANSGENIC MOUSE;

ANIMALS; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HEALTH STATUS DISPARITIES; HUMANS; MALE; MICE, TRANSGENIC; PHENOTYPE; PROTECTIVE FACTORS; RISK FACTORS; SEX CHROMOSOMES; SEX FACTORS;

EID: 85014756004     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.116.307301     Document Type: Review

References (138)

1. US National Institute of Medicine Committee on Understanding the Biology of Sex and Gender Disorders Exploring the Biological Contributions to Human Health: Does Sex Matter? 2001 Washington, DC National Academy Press
2. Maric-Bilkan C, Arnold AP, Taylor DA, Dwinell M, Howlett SE, Wenger N, Reckelhoff JF, Sandberg K, Churchill G, Levin E, Lundberg MS, Report of the National Heart, Lung, and Blood Institute Working Group on sex differences research in cardiovascular disease: scientific questions and challenges. Hypertension 2016 67 802 807. doi: 10.1161/HYPERTENSIONAHA.115.06967.
3. Leening MJ, Ferket BS, Steyerberg EW, Kavousi M, Deckers JW, Nieboer D, Heeringa J, Portegies ML, Hofman A, Ikram MA, Hunink MG, Franco OH, Stricker BH, Witteman JC, Roos-Hesselink JW, Sex differences in lifetime risk and first manifestation of cardiovascular disease: prospective population based cohort study. BMJ 2014 349 g5992
4. Mozaffarian D, Benjamin EJ, Go AS, American Heart Association Statistics Committee and Stroke Statistics Subcommittee Heart disease and stroke statistics-2015 update: a report from the American Heart Association. Circulation 2015 131 e29 322. doi: 10.1161/CIR.0000000000000152.
5. Shi A, Tao Z, Wei P, Zhao J, Epidemiological aspects of heart diseases. Exp Ther Med 2016 12 1645 1650. doi: 10.3892/etm.2016.3541.
6. Puckrein GA, Egan BM, Howard G, Social and medical determinants of cardiometabolic health: the big picture. Ethn Dis 2015 25 521 524. doi: 10.18865/ed.25.4.521.
7. Pickering TG, The effects of environmental and lifestyle factors on blood pressure and the intermediary role of the sympathetic nervous system. J Hum Hypertens 1997 11 suppl 1 S9 S18
8. Arnold AP, The end of gonad-centric sex determination in mammals. Trends Genet 2012 28 55 61. doi: 10.1016/j.tig.2011.10.004.
9. Eggers S, Ohnesorg T, Sinclair A, Genetic regulation of mammalian gonad development. Nat Rev Endocrinol 2014 10 673 683. doi: 10.1038/nrendo.2014.163.
10. Arnold AP, The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues. Horm Behav 2009 55 570 578. doi: 10.1016/j.yhbeh.2009.03.011.
11. Dewing P, Chiang CW, Sinchak K, Sim H, Fernagut PO, Kelly S, Chesselet MF, Micevych PE, Albrecht KH, Harley VR, Vilain E, Direct regulation of adult brain function by the male-specific factor SRY. Curr Biol 2006 16 415 420. doi: 10.1016/j.cub.2006.01.017.
12. Loke H, Harley V, Lee J, Biological factors underlying sex differences in neurological disorders. Int J Biochem Cell Biol 2015 65 139 150. doi: 10.1016/j.biocel.2015.05.024.
13. Ely D, Underwood A, Dunphy G, Boehme S, Turner M, Milsted A, Review of the Y chromosome, Sry and hypertension. Steroids 2010 75 747 753. doi: 10.1016/j.steroids.2009.10.015.
14. Case LK, Teuscher C, Y genetic variation and phenotypic diversity in health and disease. Biol Sex Differ 2015 6 6. doi: 10.1186/s13293-015-0024-z.
15. Disteche CM, Dosage compensation of the sex chromosomes. Annu Rev Genet 2012 46 537 560. doi: 10.1146/annurev-genet-110711-155454.
16. Balaton BP, Brown CJ, Escape artists of the X chromosome. Trends Genet 2016 32 348 359. doi: 10.1016/j.tig.2016.03.007.
17. Chen X, McClusky R, Chen J, Beaven SW, Tontonoz P, Arnold AP, Reue K, The number of x chromosomes causes sex differences in adiposity in mice. PLoS Genet 2012 8 e1002709. doi: 10.1371/journal.pgen.1002709.
18. Li J, Chen X, McClusky R, Ruiz-Sundstrom M, Itoh Y, Umar S, Arnold AP, Eghbali M, The number of X chromosomes influences protection from cardiac ischaemia/reperfusion injury in mice: one X is better than two. Cardiovasc Res 2014 102 375 384. doi: 10.1093/cvr/cvu064.
19. Bellott DW, Hughes JF, Skaletsky H, Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 2014 508 494 499. doi: 10.1038/nature13206.
20. Wijchers PJ, Festenstein RJ, Epigenetic regulation of autosomal gene expression by sex chromosomes. Trends Genet 2011 27 132 140. doi: 10.1016/j.tig.2011.01.004.
21. Becker JB, Arnold AP, Berkley KJ, Blaustein JD, Eckel LA, Hampson E, Herman JP, Marts S, Sadee W, Steiner M, Taylor J, Young E, Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005 146 1650 1673. doi: 10.1210/en.2004-1142.
22. Arnold AP, Conceptual frameworks and mouse models for studying sex differences in physiology and disease: why compensation changes the game. Exp Neurol 2014 259 2 9. doi: 10.1016/j.expneurol.2014.01.021.
23. Eicher EM, Hale DW, Hunt PA, Lee BK, Tucker PK, King TR, Eppig JT, Washburn LL, The mouse Y∗ chromosome involves a complex rearrangement, including interstitial positioning of the pseudoautosomal region. Cytogenet Cell Genet 1991 57 221 230
24. Burgoyne PS, Mahadevaiah SK, Perry J, Palmer SJ, Ashworth A, The Y∗ rearrangement in mice: new insights into a perplexing PAR. Cytogenet Cell Genet 1998 80 37 40
25. Chen X, McClusky R, Itoh Y, Reue K, Arnold AP, X and Y chromosome complement influence adiposity and metabolism in mice. Endocrinology 2013 154 1092 1104. doi: 10.1210/en.2012-2098.
26. Arnold AP, Chen X, What does the "four core genotypes" mouse model tell us about sex differences in the brain and other tissues? Front Neuroendocrinol 2009 30 1 9. doi: 10.1016/j.yfrne.2008.11.001.
27. Fried SK, Lee MJ, Karastergiou K, Shaping fat distribution: new insights into the molecular determinants of depot- and sex-dependent adipose biology. Obesity (Silver Spring) 2015 23 1345 1352. doi: 10.1002/oby.21133.
28. Palmer BF, Clegg DJ, The sexual dimorphism of obesity. Mol Cell Endocrinol 2015 402 113 119. doi: 10.1016/j.mce.2014.11.029.
29. Mauvais-Jarvis F, Sex differences in metabolic homeostasis, diabetes, and obesity. Biol Sex Differ 2015 6 14. doi: 10.1186/s13293-015-0033-y.
30. Parks BW, Sallam T, Mehrabian M, Genetic architecture of insulin resistance in the mouse. Cell Metab 2015 21 334 346. doi: 10.1016/j.cmet.2015.01.002.
31. Parks BW, Nam E, Org E, Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice. Cell Metab 2013 17 141 152. doi: 10.1016/j.cmet.2012.12.007.
32. Santosa S, Jensen MD, The sexual dimorphism of lipid kinetics in humans. Front Endocrinol (Lausanne) 2015 6 103. doi: 10.3389/fendo.2015.00103.
33. Law J, Bloor I, Budge H, Symonds ME, The influence of sex steroids on adipose tissue growth and function. Horm Mol Biol Clin Investig 2014 19 13 24. doi: 10.1515/hmbci-2014-0015.
34. Wang X, Magkos F, Mittendorfer B, Sex differences in lipid and lipoprotein metabolism: it's not just about sex hormones. J Clin Endocrinol Metab 2011 96 885 893. doi: 10.1210/jc.2010-2061.
35. Winkler TW, Justice AE, Graff M, CHARGE Consortium; DIAGRAM Consortium; GLGC Consortium; Global-BPGen Consortium; ICBP Consortium; MAGIC Consortium The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet 2015 11 e1005378. doi: 10.1371/journal.pgen.1005378.
36. Sung YJ, Pérusse L, Sarzynski MA, Genome-wide association studies suggest sex-specific loci associated with abdominal and visceral fat. Int J Obes (Lond) 2016 40 662 674. doi: 10.1038/ijo.2015.217.
37. Bennett BJ, Davis RC, Civelek M, Genetic architecture of atherosclerosis in mice: a systems genetics analysis of common inbred strains. PLoS Genet 2015 11 e1005711. doi: 10.1371/journal.pgen.1005711.
38. Link JC, Chen X, Prien C, Borja MS, Hammerson B, Oda MN, Arnold AP, Reue K, Increased high-density lipoprotein cholesterol levels in mice with XX versus XY sex chromosomes. Arterioscler Thromb Vasc Biol 2015 35 1778 1786. doi: 10.1161/ATVBAHA.115.305460.
39. Heberden W, Willis FA, Keys TE, Commentaries on the history and cure of diseases. In: Cardiac Classics 1941 St. Louis C.V. Mosby 224
40. McGill HC, Stern MP, Sex and atherosclerosis. Atheroscler Rev 1979 4 157 242
41. Peters SA, Singhateh Y, Mackay D, Huxley RR, Woodward M, Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis 2016 248 123 131. doi: 10.1016/j.atherosclerosis.2016.03.016.
42. Gälman C, Angelin B, Rudling M, Pronounced variation in bile acid synthesis in humans is related to gender, hypertriglyceridaemia and circulating levels of fibroblast growth factor 19. J Intern Med 2011 270 580 588. doi: 10.1111/j.1365-2796.2011.02466.x.
43. Middelberg RP, Spector TD, Swaminathan R, Snieder H, Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 2002 22 1142 1147
44. Kannel WB, Hjortland MC, McNamara PM, Gordon T, Menopause and risk of cardiovascular disease: the Framingham study. Ann Intern Med 1976 85 447 452
45. Guthrie JR, Taffe JR, Lehert P, Burger HG, Dennerstein L, Association between hormonal changes at menopause and the risk of a coronary event: a longitudinal study. Menopause 2004 11 315 322
46. Oliver MF, Boyd GS, Effect of bilateral ovariectomy on coronary-artery disease and serum-lipid levels. Lancet 1959 2 690 694
47. Cauley JA, Gutai JP, Glynn NW, Paternostro-Bayles M, Cottington E, Kuller LH, Serum estrone concentrations and coronary artery disease in postmenopausal women. Arterioscler Thromb 1994 14 14 18
48. Kumagai S, Kai Y, Sasaki H, Relationship between insulin resistance, sex hormones and sex hormone-binding globulin in the serum lipid and lipoprotein profiles of Japanese postmenopausal women. J Atheroscler Thromb 2001 8 14 20
49. Mudali S, Dobs AS, Ding J, Cauley JA, Szklo M, Golden SH, Atherosclerosis Risk in Communities Study Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. J Clin Endocrinol Metab 2005 90 1202 1209. doi: 10.1210/jc.2004-0744.
50. Farias JM, Tinetti M, Khoury M, Umpierrez GE, Low testosterone concentration and atherosclerotic disease markers in male patients with type 2 diabetes. J Clin Endocrinol Metab 2014 99 4698 4703. doi: 10.1210/jc.2014-2585.
51. Shores MM, Matsumoto AM, Testosterone, aging and survival: biomarker or deficiency. Curr Opin Endocrinol Diabetes Obes 2014 21 209 216. doi: 10.1097/MED.0000000000000057.
52. Muller M, van den Beld AW, Bots ML, Grobbee DE, Lamberts SW, van der Schouw YT, Endogenous sex hormones and progression of carotid atherosclerosis in elderly men. Circulation 2004 109 2074 2079. doi: 10.1161/01.CIR.0000125854.51637.06.
53. Lee WC, Kim MT, Ko KT, Lee WK, Kim SY, Kim HY, Yang DY, Relationship between serum testosterone and cardiovascular disease risk determined using the Framingham risk score in male patients with sexual dysfunction. World J Mens Health 2014 32 139 144. doi: 10.5534/wjmh.2014.32.3.139.
54. Gutai J, LaPorte R, Kuller L, Dai W, Falvo-Gerard L, Caggiula A, Plasma testosterone, high density lipoprotein cholesterol and other lipoprotein fractions. Am J Cardiol 1981 48 897 902
55. Heller RF, Miller NE, Lewis B, Vermeulen A, Fairney A, James VH, Swan AV, Associations between sex hormones, thyroid hormones and lipoproteins. Clin Sci (Lond) 1981 61 649 651
56. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS, Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991 133 884 899
57. Eissa MA, Mihalopoulos NL, Holubkov R, Dai S, Labarthe DR, Changes in fasting lipids during puberty. J Pediatr 2016 170 199 205. doi: 10.1016/j.jpeds.2015.11.018.
58. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman MR, Baltimore Longitudinal Study of Aging Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging. J Clin Endocrinol Metab 2001 86 724 731. doi: 10.1210/jcem.86.2.7219.
59. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA, Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011 96 3007 3019. doi: 10.1210/jc.2011-1137.
60. Corona G, Monami M, Boddi V, Rastrelli G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M, Pulse pressure independently predicts major cardiovascular events in younger but not in older subjects with erectile dysfunction. J Sex Med 2011 8 247 254. doi: 10.1111/j.1743-6109.2010.01966.x.
61. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM, Endogenous testosterone and cardiovascular disease in healthy men: a meta-analysis. Heart 2011 97 870 875. doi: 10.1136/hrt.2010.210757.
62. Hak AE, Witteman JC, de Jong FH, Geerlings MI, Hofman A, Pols HA, Low levels of endogenous androgens increase the risk of atherosclerosis in elderly men: the Rotterdam study. J Clin Endocrinol Metab 2002 87 3632 3639. doi: 10.1210/jcem.87.8.8762.
63. Rosano GM, Sheiban I, Massaro R, Pagnotta P, Marazzi G, Vitale C, Mercuro G, Volterrani M, Aversa A, Fini M, Low testosterone levels are associated with coronary artery disease in male patients with angina. Int J Impot Res 2007 19 176 182. doi: 10.1038/sj.ijir.3901504.
64. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E, Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998 280 605 613
65. Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J, Writing Group for the Women's Health Initiative Investigators Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA 2002 288 321 333
66. Manson JE, Hsia J, Johnson KC, Rossouw JE, Assaf AR, Lasser NL, Trevisan M, Black HR, Heckbert SR, Detrano R, Strickland OL, Wong ND, Crouse JR, Stein E, Cushman M, Women's Health Initiative Investigators Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003 349 523 534. doi: 10.1056/NEJMoa030808.
67. US Preventative Services Task Force Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the US Preventative Services Task Force. Ann Intern Med 2005 142 855 860
68. Hodis HN, Mack WJ, Henderson VW, Shoupe D, Budoff MJ, Hwang-Levine J, Li Y, Feng M, Dustin L, Kono N, Stanczyk FZ, Selzer RH, Azen SP, ELITE Research Group Vascular effects of early versus late postmenopausal treatment with estradiol. N Engl J Med 2016 374 1221 1231. doi: 10.1056/NEJMoa1505241.
69. Getz GS, Reardon CA, Animal models of atherosclerosis. Arterioscler Thromb Vasc Biol 2012 32 1104 1115. doi: 10.1161/ATVBAHA.111.237693.
70. Moore KJ, Sheedy FJ, Fisher EA, Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 2013 13 709 721. doi: 10.1038/nri3520.
71. Smith DD, Tan X, Tawfik O, Milne G, Stechschulte DJ, Dileepan KN, Increased aortic atherosclerotic plaque development in female apolipoprotein E-null mice is associated with elevated thromboxane A2 and decreased prostacyclin production. J Physiol Pharmacol 2010 61 309 316
72. Tangirala RK, Rubin EM, Palinski W, Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J Lipid Res 1995 36 2320 2328
73. Caligiuri G, Nicoletti A, Zhou X, Törnberg I, Hansson GK, Effects of sex and age on atherosclerosis and autoimmunity in apoE-deficient mice. Atherosclerosis 1999 145 301 308
74. Hodgin JB, Maeda N, Minireview: estrogen and mouse models of atherosclerosis. Endocrinology 2002 143 4495 4501. doi: 10.1210/endo.143.12.9995.
75. Marsh MM, Walker VR, Curtiss LK, Banka CL, Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice. J Lipid Res 1999 40 893 900
76. Elhage R, Arnal JF, Pieraggi MT, Duverger N, Fiévet C, Faye JC, Bayard F, 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 1997 17 2679 2684
77. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ, Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 1996 93 10022 10027
78. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N, Estrogen receptor alpha is a major mediator of 17beta-estradiol's atheroprotective effects on lesion size in Apoe-/- mice. J Clin Invest 2001 107 333 340. doi: 10.1172/JCI11320.
79. Billon-Galés A, Fontaine C, Douin-Echinard V, Delpy L, Berges H, Calippe B, Lenfant F, Laurell H, Guéry JC, Gourdy P, Arnal JF, Endothelial estrogen receptor-alpha plays a crucial role in the atheroprotective action of 17beta-estradiol in low-density lipoprotein receptor-deficient mice. Circulation 2009 120 2567 2576. doi: 10.1161/CIRCULATIONAHA.109.898445.
80. Villablanca AC, Tenwolde A, Lee M, Huck M, Mumenthaler S, Rutledge JC, 17beta-estradiol prevents early-stage atherosclerosis in estrogen receptor-alpha deficient female mice. J Cardiovasc Transl Res 2009 2 289 299. doi: 10.1007/s12265-009-9103-z.
81. Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F, Gourdy P, Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol 2010 30 1506 1512. doi: 10.1161/ATVBAHA.109.191221.
82. Chow RW, Handelsman DJ, Ng MK, Minireview: rapid actions of sex steroids in the endothelium. Endocrinology 2010 151 2411 2422. doi: 10.1210/en.2009-1456.
83. Mikkola T, Turunen P, Avela K, Orpana A, Viinikka L, Ylikorkala O, 17 beta-estradiol stimulates prostacyclin, but not endothelin-1, production in human vascular endothelial cells. J Clin Endocrinol Metab 1995 80 1832 1836. doi: 10.1210/jcem.80.6.7775630.
84. Mikkola T, Ranta V, Orpana A, Ylikorkala O, Viinikka L, Effect of physiological concentrations of estradiol on PGI2 and NO in endothelial cells. Maturitas 1996 25 141 147
85. Badeau RM, Metso J, Wähälä K, Tikkanen MJ, Jauhiainen M, Human macrophage cholesterol efflux potential is enhanced by HDL-associated 17beta-estradiol fatty acyl esters. J Steroid Biochem Mol Biol 2009 116 44 49. doi: 10.1016/j.jsbmb.2009.04.008.
86. Frazier-Jessen MR, Kovacs EJ, Estrogen modulation of JE/monocyte chemoattractant protein-1 mRNA expression in murine macrophages. J Immunol 1995 154 1838 1845
87. Deshpande R, Khalili H, Pergolizzi RG, Michael SD, Chang MD, Estradiol down-regulates LPS-induced cytokine production and NFkB activation in murine macrophages. Am J Reprod Immunol 1997 38 46 54
88. Vegeto E, Ghisletti S, Meda C, Etteri S, Belcredito S, Maggi A, Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells. J Steroid Biochem Mol Biol 2004 91 59 66. doi: 10.1016/j.jsbmb.2004.02.004.
89. Dai-Do D, Espinosa E, Liu G, Rabelink TJ, Julmy F, Yang Z, Mahler F, Lüscher TF, 17 beta-estradiol inhibits proliferation and migration of human vascular smooth muscle cells: similar effects in cells from postmenopausal females and in males. Cardiovasc Res 1996 32 980 985
90. Suzuki A, Mizuno K, Ino Y, Okada M, Kikkawa F, Mizutani S, Tomoda Y, Effects of 17 beta-estradiol and progesterone on growth-factor-induced proliferation and migration in human female aortic smooth muscle cells in vitro. Cardiovasc Res 1996 32 516 523
91. Nguyen CP, Hirsch MS, Moeny D, Kaul S, Mohamoud M, Joffe HV, Testosterone and "age-related hypogonadism"-FDA concerns. N Engl J Med 2015 373 689 691. doi: 10.1056/NEJMp1506632.
92. Casquero AC, Berti JA, Salerno AG, Bighetti EJ, Cazita PM, Ketelhuth DF, Gidlund M, Oliveira HC, Atherosclerosis is enhanced by testosterone deficiency and attenuated by CETP expression in transgenic mice. J Lipid Res 2006 47 1526 1534. doi: 10.1194/jlr.M600135-JLR200.
93. von DG, von DO, Volker W, Langer C, Weinbauer GF, Behre HM, Nieschlag E, Assmann G, von EA, Atherosclerosis in apolipoprotein E-deficient mice is decreased by the suppression of endogenous sex hormones. Horm Metab Res 2001 33 110 114
94. Henriques TA, Huang J, D'Souza SS, Daugherty A, Cassis LA, Orchidectomy, but not ovariectomy, regulates angiotensin II-induced vascular diseases in apolipoprotein E-deficient mice. Endocrinology 2004 145 3866 3872. doi: 10.1210/en.2003-1615.
95. Mukherjee TK, Dinh H, Chaudhuri G, Nathan L, Testosterone attenuates expression of vascular cell adhesion molecule-1 by conversion to estradiol by aromatase in endothelial cells: implications in atherosclerosis. Proc Natl Acad Sci USA 2002 99 4055 4060. doi: 10.1073/pnas.052703199.
96. Qiu Y, Yanase T, Hu H, Tanaka T, Nishi Y, Liu M, Sueishi K, Sawamura T, Nawata H, Dihydrotestosterone suppresses foam cell formation and attenuates atherosclerosis development. Endocrinology 2010 151 3307 3316. doi: 10.1210/en.2009-1268.
97. McRobb L, Handelsman DJ, Heather AK, Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels. Endocrinology 2009 150 841 848. doi: 10.1210/en.2008-0760.
98. Higgins CD, Swerdlow AJ, Schoemaker MJ, Wright AF, Jacobs PA, UK Clinical Cytogenetics Group Mortality and cancer incidence in males with Y polysomy in Britain: a cohort study. Hum Genet 2007 121 691 696. doi: 10.1007/s00439-007-0365-8.
99. Charchar FJ, Bloomer LD, Barnes TA, Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet 2012 379 915 922. doi: 10.1016/S0140-6736(11)61453-0.
100. Van PL, Bakalov VK, Bondy CA, Monosomy for the X-chromosome is associated with an atherogenic lipid profile. J Clin Endocrinol Metab 2006 91 2867 2870. doi: 10.1210/jc.2006-0503.
101. Gravholt CH, Juul S, Naeraa RW, Hansen J, Morbidity in Turner syndrome. J Clin Epidemiol 1998 51 147 158
102. Hannawa KK, Eliason JL, Upchurch GR Jr., Gender differences in abdominal aortic aneurysms. Vascular 2009 17 suppl 1 S30 S39
103. Makrygiannis G, Courtois A, Drion P, Defraigne JO, Kuivaniemi H, Sakalihasan N, Sex differences in abdominal aortic aneurysm: the role of sex hormones. Ann Vasc Surg 2014 28 1946 1958. doi: 10.1016/j.avsg.2014.07.008.
104. Cosford PA, Leng GC, Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007 CD002945
105. Guirguis-Blake JM, Beil TL, Senger CA, Whitlock EP, Ultrasonography screening for abdominal aortic aneurysms: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med 2014 160 321 329. doi: 10.7326/M13-1844.
106. Grootenboer N, Bosch JL, Hendriks JM, van Sambeek MR, Epidemiology, aetiology, risk of rupture and treatment of abdominal aortic aneurysms: does sex matter? Eur J Vasc Endovasc Surg 2009 38 278 284. doi: 10.1016/j.ejvs.2009.05.004.
107. Skibba AA, Evans JR, Hopkins SP, Yoon HR, Katras T, Kalbfleisch JH, Rush DS, Reconsidering gender relative to risk of rupture in the contemporary management of abdominal aortic aneurysms. J Vasc Surg 2015 62 1429 1436. doi: 10.1016/j.jvs.2015.07.079.
108. Sweeting MJ, Thompson SG, Brown LC, Powell JT, RESCAN collaborators Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012 99 655 665. doi: 10.1002/bjs.8707.
109. Stuntz M, Modeling the burden of abdominal aortic aneurysm in the USA in 2013. Cardiology 2016 135 127 131
110. Laser A, Ghosh A, Roelofs K, Sadiq O, McEvoy B, DiMusto P, Eliason J, Upchurch GR Jr., Increased estrogen receptor alpha in experimental aortic aneurysms in females compared with males. J Surg Res 2014 186 467 474. doi: 10.1016/j.jss.2013.07.050.
111. Johnston WF, Salmon M, Su G, Lu G, Ailawadi G, Upchurch GR Jr., Aromatase is required for female abdominal aortic aneurysm protection. J Vasc Surg 2015 61 1565 74.e1. doi: 10.1016/j.jvs.2014.01.032.
112. Martin-McNulty B, Tham DM, da Cunha V, Ho JJ, Wilson DW, Rutledge JC, Deng GG, Vergona R, Sullivan ME, Wang YX, 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003 23 1627 1632. doi: 10.1161/01.ATV.0000085842.20866.6A.
113. Thatcher SE, Zhang X, Woody S, Wang Y, Alsiraj Y, Charnigo R, Daugherty A, Cassis LA, Exogenous 17-β estradiol administration blunts progression of established angiotensin II-induced abdominal aortic aneurysms in female ovariectomized mice. Biol Sex Differ 2015 6 12. doi: 10.1186/s13293-015-0030-1.
114. Henriques T, Zhang X, Yiannikouris FB, Daugherty A, Cassis LA, Androgen increases AT1a receptor expression in abdominal aortas to promote angiotensin II-induced AAAs in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2008 28 1251 1256. doi: 10.1161/ATVBAHA.107.160382.
115. Zhang X, Thatcher SE, Rateri DL, Bruemmer D, Charnigo R, Daugherty A, Cassis LA, Transient exposure of neonatal female mice to testosterone abrogates the sexual dimorphism of abdominal aortic aneurysms. Circ Res 2012 110 e73 e85. doi: 10.1161/CIRCRESAHA.111.253880.
116. Zhang X, Thatcher S, Wu C, Daugherty A, Cassis LA, Castration of male mice prevents the progression of established angiotensin II-induced abdominal aortic aneurysms. J Vasc Surg 2015 61 767 776. doi: 10.1016/j.jvs.2013.11.004.
117. Alsiraj Y, Thatcher SE, Charnigo R, Chen K, Blalock E, Daugherty A, Cassis LA, Female mice with an XY sex chromosome complement develop severe angiotensin II-induced abdominal aortic aneurysms. Circulation 2017 135 379 391. doi: 10.1161/CIRCULATIONAHA.116.023789.
118. Hayward CS, Kelly RP, Collins P, The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 2000 46 28 49
119. Parker WH, Jacoby V, Shoupe D, Rocca W, Effect of bilateral oophorectomy on women's long-term health. Womens Health (Lond) 2009 5 565 576. doi: 10.2217/whe.09.42.
120. Song X, Li G, Vaage J, Valen G, Effects of sex, gonadectomy, and oestrogen substitution on ischaemic preconditioning and ischaemia-reperfusion injury in mice. Acta Physiol Scand 2003 177 459 466. doi: 10.1046/j.1365-201X.2003.01068.x.
121. Ostadal B, Netuka I, Maly J, Besik J, Ostadalova I, Gender differences in cardiac ischemic injury and protection-experimental aspects. Exp Biol Med (Maywood) 2009 234 1011 1019. doi: 10.3181/0812-MR-362.
122. Lin J, Steenbergen C, Murphy E, Sun J, Estrogen receptor-beta activation results in S-nitrosylation of proteins involved in cardioprotection. Circulation 2009 120 245 254. doi: 10.1161/CIRCULATIONAHA.109.868729.
123. Lagranha CJ, Deschamps A, Aponte A, Steenbergen C, Murphy E, Sex differences in the phosphorylation of mitochondrial proteins result in reduced production of reactive oxygen species and cardioprotection in females. Circ Res 2010 106 1681 1691. doi: 10.1161/CIRCRESAHA.109.213645.
124. Albrektsen G, Heuch I, Løchen ML, Thelle DS, Wilsgaard T, Njølstad I, Bønaa KH, Lifelong gender gap in risk of incident myocardial infarction: the Tromsø study. JAMA Intern Med 2016 176 1673 1679. doi: 10.1001/jamainternmed.2016.5451.
125. Mosca L, Barrett-Connor E, Wenger NK, Sex/gender differences in cardiovascular disease prevention: what a difference a decade makes. Circulation 2011 124 2145 2154. doi: 10.1161/CIRCULATIONAHA.110.968792.
126. Parker WH, Ovarian conservation versus bilateral oophorectomy at the time of hysterectomy for benign disease. Menopause 2014 21 192 194. doi: 10.1097/GME.0b013e31829be0a0.
127. World Heart Federation. http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/hypertension/
128. Sandberg K, Ji H, Sex differences in primary hypertension. Biol Sex Differ 2012 3 7. doi: 10.1186/2042-6410-3-7.
129. Pollow DP, Uhrlaub J, Romero-Aleshire MJ, Sandberg K, Nikolich-Zugich J, Brooks HL, Hay M, Sex differences in T-lymphocyte tissue infiltration and development of angiotensin II hypertension. Hypertension 2014 64 384 390. doi: 10.1161/HYPERTENSIONAHA.114.03581.
130. Ji H, Zheng W, Li X, Liu J, Wu X, Zhang MA, Umans JG, Hay M, Speth RC, Dunn SE, Sandberg K, Sex-specific T-cell regulation of angiotensin II-dependent hypertension. Hypertension 2014 64 573 582. doi: 10.1161/HYPERTENSIONAHA.114.03663.
131. Ji H, Zheng W, Wu X, Liu J, Ecelbarger CM, Watkins R, Arnold AP, Sandberg K, Sex chromosome effects unmasked in angiotensin II-induced hypertension. Hypertension 2010 55 1275 1282. doi: 10.1161/HYPERTENSIONAHA.109.144949.
132. Pessôa BS, Slump DE, Ibrahimi K, Grefhorst A, van Veghel R, Garrelds IM, Roks AJ, Kushner SA, Danser AH, van Esch JH, Angiotensin II type 2 receptor- and acetylcholine-mediated relaxation: essential contribution of female sex hormones and chromosomes. Hypertension 2015 66 396 402. doi: 10.1161/HYPERTENSIONAHA.115.05303.
133. Vasan RS, Larson MG, Leip EP, Evans JC, O'Donnell CJ, Kannel WB, Levy D, Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med 2001 345 1291 1297. doi: 10.1056/NEJMoa003417.
134. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB, General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008 117 743 753. doi: 10.1161/CIRCULATIONAHA.107.699579.
135. Dantas AP, Franco Mdo C, Silva-Antonialli MM, Tostes RC, Fortes ZB, Nigro D, Carvalho MH, Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 2004 61 22 29
136. Arnold AP, Chen X, Link JC, Itoh Y, Reue K, Cell-autonomous sex determination outside of the gonad. Dev Dyn 2013 242 371 379. doi: 10.1002/dvdy.23936.
137. Murphy E, Steenbergen C, Sex, drugs, and trial design: sex influences the heart and drug responses. J Clin Invest 2014 124 2375 2377. doi: 10.1172/JCI76262.
138. Incidence and Prevalence: 2006 Chart Book on Cardiovascular and Lung Diseases 2016 Bethesda MD National Heart, Lung, and Blood Institute